NR5A2/HSD3B1 pathway promotes cellular resistance to second-generation antiandrogen darolutamide-Reference-Cited by-同舟云学术

NR5A2/HSD3B1 pathway promotes cellular resistance to second-generation antiandrogen darolutamide

Published:2023-09 Issue: Volume:70 Page:100990
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Shiota Masaki^ORCID,Ushijima Miho,Tsukahara Shigehiro,Nagakawa Shohei,Blas Leandro,Takamatsu Dai,Kobayashi Satoshi,Matsumoto Takashi,Inokuchi Junichi,Eto Masatoshi

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference15 articles.

1. The human androgen receptor: domain structure, genomic organization and regulation of expression;Brinkmann;J. Steroid Biochem,1989

2. A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer;Chang;Cell,2013

3. Cancer-associated fibroblast-secreted glucosamine alters the androgen biosynthesis program in prostate cancer via HSD3B1 upregulation;Cui;J. Clin. Invest,2023

4. Nonmetastatic, castration-resistant prostate cancer and survival with darolutamide;Fizazi;New Engl. J. Med.,2020

5. Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer;Liu;Cancer Res.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative stress in peroxisomes induced by androgen receptor inhibition through peroxisome proliferator–activated receptor promotes enzalutamide resistance in prostate cancer;Free Radical Biology and Medicine;2024-08

2. Importance of 3β-hydroxysteroid dehydrogenases and their clinical use in prostate cancer;Endocrine-Related Cancer;2024-04-29

3. NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score;Heliyon;2024-04